NSCLC, Stage I
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| tas6417 | CG Oncology, Inc. (CGON) |
Frequently asked questions
How many drugs are in development for NSCLC, Stage I?
BioSniper tracks 1 drug in development for NSCLC, Stage I across 1 company.
How many clinical trials target NSCLC, Stage I?
There are 2 clinical trials targeting NSCLC, Stage I tracked by BioSniper.
Deep-dive into NSCLC, Stage I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis